Controlling severe atopic dermatitis dynamics
Chaos: An Interdisciplinary Journal of Nonlinear Science · 01.03.2026 · 36 (3)
DOI: 10.1063/5.0308283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chaos: An Interdisciplinary Journal of Nonlinear Science, online erschienen am 17.03.2026. Verfasst von Yoseb Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, Institute for Future Earth, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Models, Biological. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, US Army Research Office.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a pervasive inflammatory skin disease, with severe forms constituting a refractory phenotype that devastates quality of life through relentless pruritus, widespread lesions, and resistance to standard therapies. A central clinical challenge is to steer the disease away from chronic inflammation and sustain remission. Framed in dynamical terms, this amounts to controlling the remission dynamics of AD. We establish a mathematical framework for the canonical two-phase clinical strategy: the “Get Control” (GC) phase, where antibiotics are administered to suppress acute inflammation, and the “Keep Control” (KC) phase, where emollients are applied to maintain remission. A key question of therapeutic relevance is: what are the minimal drug doses required for each phase to succeed? Our analysis reveals scaling laws that tie the control amplitude (drug dose) directly to two fundamental determinants of severe AD: barrier permeability and immune clearance capacity. These laws delineate the antibiotic dosage required to exit chronic inflammation in GC and the emollient level needed to sustain remission in KC. The uncovered scaling principles elevate treatment design from heuristic to quantitative, leading to a theoretical framework for precision, phase-based analysis of treatment control in severe AD. By aligning clinical intervention with the dynamical structure of the disease, the framework points toward personalized, optimally dosed strategies for overcoming refractory cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Mathematics, Institute for Future Earth, Pusan National University, Busan 46241, Republic of Korea.
- School of Electrical, Computer and Energy Engineering, Arizona State University, Tempe, Arizona 85287, USA.
- Department of Physics, Arizona State University, Tempe, Arizona 85287, USA.
ORCID-Profile: Yoseb Kang, Ying-Cheng Lai
Förderung
- National Research Foundation of Korea
- US Army Research Office
Zitieren
APA
Kang, Y., & Lai, Y. C. (2026). Controlling severe atopic dermatitis dynamics. Chaos: An Interdisciplinary Journal of Nonlinear Science, 36(3). https://doi.org/10.1063/5.0308283
Vancouver
Kang Y, Lai YC. Controlling severe atopic dermatitis dynamics. Chaos: An Interdisciplinary Journal of Nonlinear Science. 2026;36(3). doi:10.1063/5.0308283
BibTeX
@article{Kang2026,
author = {Kang, Yoseb and Lai, Ying-Cheng},
title = {Controlling severe atopic dermatitis dynamics},
journal = {Chaos: An Interdisciplinary Journal of Nonlinear Science},
year = {2026},
volume = {36},
number = {3},
doi = {10.1063/5.0308283}
}
EUVIMED